Company intelligence / Profile preview

Sano Genetics

Cambridge, England, United Kingdomsanogenetics.com ↗

Ownership: Private
Employees: ~70
Development stage: Commercial

Overview

Sano Genetics provides an integrated digital platform that accelerates precision medicine clinical trials by combining patient recruitment, genetic/biomarker testing, electronic medical record retrieval, and long-term participant engagement. The company has demonstrated success in supporting large-scale genomics projects and enabling faster enrollment for complex trials such as those in Parkinson’s disease and Long COVID.

Therapeutic areas: Metabolic DisordersNeurologyInfectious Diseases
Modalities: Genetic testingBiomarker testing
Industry: Contract Research Organization

Partnerships

Neuron23Owlstone MedicalFour of the top twenty global pharmaceutical companies

Beyond the preview

Go deeper on Sano Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sano Genetics.

Explore the full profile